Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit

威尔康奈尔医学院新泽西医学院临床试验单位

• 批准号: 8609726
• 负责人: ROY M. GULICK
• 金额: $ 245.66万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-01-10 至 2020-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8609726
• 关键词: AIDS prevention; Affect; African American; American; Area; Back; Clinical Research; Clinical Trials Unit; Communities; Diagnostic; Enrollment; HIV; HIV Infections; HIV Seroprevalence; Hepatitis C virus; Individual; Joints; Laboratories; Life; Malignant Neoplasms; Mono-S; National Institute of Allergy and Infectious Disease; Neighborhoods; New Jersey; New York City; Participant; Pharmacy facility; Population; Prevention Research; Prophylactic treatment; Research Personnel; Research Support; Risk; Seroprevalences; Shapes; Site; Training; Tuberculosis; Work; clinical research site; data management; experience; medical schools; metropolitan; novel; patient population; prevent; quality assurance

DESCRIPTION (provided by applicant): The Weill Cornell Medical College - New Jersey Medical School Clinical Trials Unit (WCMC-NJMS CTU) will conduct National Institute of Allergy and Infectious Diseases (NIAID)-sponsored network studies of HIV treatment and HIV prevention and enroll participants from communities of the New York City (NYC)-Newark metropolitan area, the epicenter of HIV in the U.S. The unit consists of a central core and three clinical research sites (CRS). The WCMC-NJMS CTU provides central research support to the three CRS, including investigative oversight; financial administration; coordination of laboratories, pharmacy, regulatory assurance, data management, quality assurance, training; and community engagement. The three CRS, WCMC-Uptown, WCMC-Chelsea, and NJMS-Newark are located in different parts of the NYC-Newark metropolitan area and serve distinct, racially and ethnically diverse patient populations of HIV-infected and at-risk individuals. WCMC-Uptown CRS is located close to Harlem, a neighborhood with an HIV seroprevalence rate of nearly 3%. The WCMC-Chelsea CRS is located in Chelsea, the neighborhood with the highest HIV seroprevalence rate in NYC of over 4%. The NJMS-Newark CRS is located in the center of Newark, and serves a predominately African American population with a seroprevalence of 3%. WCMCNJMS CTU investigators are leaders in the field who are shaping the HIV treatment and HIV prevention research agendas. They are highly experienced with expertise in non-infectious complications of HIV; HCV studies of both mono- and co-infected individuals; tuberculosis, including cutting-edge diagnostics; HIV related malignancies; novel antiretrovirals; and HIV prevention, including studies of pre-exposure prophylaxis (PrEP) to prevent HIV acquisition. Community engagement is a key strength of the WCMC-NJMS CTU with both site-specific and joint Community Advisory Boards (CAB), and a strong record of effectively communicating study results back to the community. In summary, the WCMC-NJMS CTU brings together a diverse group of recognized investigator leaders who will work with an experienced clinical research staff to conduct cutting-edge HIV treatment and HIV prevention studies in the NYC-Newark metropolitan area.

DESCRIPTION (provided by applicant): The Weill Cornell Medical College - New Jersey Medical School Clinical Trials Unit (WCMC-NJMS CTU) will conduct National Institute of Allergy and Infectious Diseases (NIAID)-sponsored network studies of HIV treatment and HIV prevention and enroll participants from communities of the New York City (NYC)-Newark metropolitan area, the epicenter of HIV in the U.S. The unit由中心核心和三个临床研究地点（CRS）组成。 WCMC-NJMS CTU为包括调查性监督在内的三个CR提供了中央研究支持；金融管理；实验室，药学，监管保证，数据管理，质量保证，培训的协调；和社区参与。 WCMC爆炸，WCMC-Chelsea和NJMS-Newark的三个CRS位于纽约市 - 纽瓦克都会区的不同地区，在HIV感染和高危人群中提供独特，种族和种族多样化的患者人群。 WCMC爆发的CRS位于Harlem附近，Harlem是HIV血清阳性率接近3％的社区。 WCMC-Chelsea CRS位于切尔西，纽约市的HIV血清阳性率最高的社区超过4％。 NJMS-Newark CRS位于纽瓦克中心，为非洲裔美国人口服务，血清阳性为3％。 WCMCNJMS CTU研究人员是该领域的领导者，他们正在塑造HIV治疗和HIV预防研究议程。他们在艾滋病毒的非感染并发症方面具有专业知识经验丰富。 HCV研究单人和共感染的个体；结核病，包括尖端诊断；艾滋病毒相关的恶性肿瘤；新型抗逆转录病毒；和预防HIV，包括对预防前预防（PREP）的研究，以防止艾滋病毒获取。社区参与是WCMC-NJMS CTU的关键优势，具有特定地点和联合社区咨询委员会（CAB），并且有效地将研究结果传达给社区。总而言之，WCMC-NJMS CTU汇集了一群公认的研究者领导者，他们将与经验丰富的临床研究人员合作，在NYC-NEWARK METROPOLITAN地区进行最先进的HIV治疗和HIV预防研究。